Tell Briefly what you care about. Every morning, get 5 stories that matter — ranked by relevance to you, with a plain-English "why it matters" for each one. No noise. No doomscrolling.
Free · Takes 2 minutes · No credit card
5 min
average read time
80+
sources scanned daily
Zero
algorithmic rabbit holes
Daily
briefing in your inbox
How it works
01
You define your world
Pick topics, add specific companies, people, or keywords. Change them any time from your dashboard.
02
We scan and filter
Briefly scans 80+ trusted sources every day, removes duplicates, and ranks what actually matters — not what's trending.
03
You get the brief
A concise daily email with an AI-written overview and a plain-English "why this matters" for each story.
04
It gets smarter
One-tap feedback on any story teaches Briefly your preferences. Your briefing sharpens over time.
What your brief looks like
⚡ AI founder
💰 VC / investor
🧬 Biotech researcher
🌱 Climate professional
Your morning brief
Today · following AI & ML, Startups, Anthropic
AIReuters · MIT Tech Review
Anthropic announces new model capability limits amid EU regulatory pressure
Why it matters to you: You track AI policy and Anthropic — this directly affects what frontier models can do in your product.
StartupsTechCrunch · Bloomberg
YC S25 batch: 40% of companies building AI infrastructure, not applications
Why it matters to you: Structural shift in where YC is placing bets — relevant if you're thinking about your company's layer in the stack.
AIThe Information
New benchmark shows frontier models hitting reasoning ceiling
Why it matters to you: You track AI capabilities — raises questions about the next capability leap and product roadmap timing.
Your morning brief
Today · following Venture capital, Finance & macro, Startups
FinanceWSJ · FT
Fed signals one rate cut in 2025 as inflation data comes in hotter than expected
Why it matters to you: Tighter-for-longer rates compress startup valuations and slow LP commitments — key signal for your deployment pace.
VCTechCrunch · Bloomberg
Sequoia raises $2.5B new fund as AI deal flow accelerates
Why it matters to you: Signals where the market is heading and who you'll be competing with for deals.
StartupsThe Information
Series A valuations drop 18% YoY as investors push for profitability
Why it matters to you: Directly affects entry pricing for your next deal — market is repricing early-stage risk.
Your morning brief
Today · following Biotech & health, Research & academia, Policy & regulation
BiotechSTAT News · Nature
FDA approves first CRISPR-based treatment for sickle cell disease
Why it matters to you: Landmark approval that opens the regulatory door for gene-editing therapies you may be working on.
ResearchScience · MIT News
AlphaFold 3 predicts protein-drug interactions with near-lab accuracy
Why it matters to you: Could accelerate your lab's drug discovery pipeline significantly.
PolicyReuters · Fierce Pharma
NIH proposes new rules on AI use in clinical trial design
Why it matters to you: Regulatory signal that will affect how you can use AI tools in your research.